An expert discusses how gene therapy represents a breakthrough treatment approach for BCG-unresponsive patients, offering ...

An expert discusses how patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) now have several ...

We’ll be back on Monday morning with more fresh content!

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

In this final video of a three-part video series, Joshua Fredell, Pharm.D., senior vice president at CVS Caremark and a ...

Sexual and gender minority individuals still face insurance denials and cost-sharing barriers when accessing pre-exposure ...

In this second part of a three-part of a video series, Kasey Raetz, Pharm.D., a PBMI Innovator, told MHE about leading the ...

To help Medicare plans better manage members with high drug expenses, Prime Therapeutics has launched an AI-driven tool to ...

The next step for the Rise For Health study researchers is to study the health benefits of frequent standing in older men and ...

Developed by Ionis Pharmaceuticals, Dawnzera is the first RNA-targeted medicine approved for HAE, designed to target plasma ...

Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive (MHE) editorial advisory board, is host of the ...

Wegovy is the first GLP-1 drug approved to treat adults with metabolic dysfunction-associated steatohepatitis (MASH). An ...